Ascendis Pharma Short and Long Term Debt Total History

Key Indicators . Short Long Term Debt Total . Stocks . USA . 
Stock . Ascendis Pharma AS
ASND Stock  USD 246.14  10.24  4.34%   
Short and Long Term Debt Total stood at 871.4 M as of December 31, 2025. Within Ascendis Pharma's balance sheet, Short and Long Term Debt Total is reported as a line item, reflecting the company's leverage and financing commitments. Over the last 16 observed reporting periods, Short and Long Term Debt Total has followed a consistent upward trajectory with strong statistical fit (R² 0.73). View All Financial Accounts
 
Short and Long Term Debt Total  
 First Reported
2018-12-31
 Previous Quarter
813.65 million
 Current Value
871.41 million
 Quarterly Volatility
328.45 million
Macro event markers
 
Covid
 
Interest Hikes

Latest Ascendis Pharma Short and Long Term Debt Total Growth Pattern

Short and Long Term Debt Total10 Years Trend
Consistent Growth
   Short Long Term Debt Total   
       Timeline  

Short and Long Term Debt Total Trend Statistics

With a CV of 145.4% across 10 observations, Ascendis Pharma's Short and Long Term Debt Total exhibits wide dispersion driven primarily by directional growth rather than instability. The R-squared of 0.73 indicates a strong linear fit indicating consistent directional movement.
Arithmetic Mean 255,480,594
Geometric Mean0.00
Coefficient Of Variation 145.41
Mean Deviation 320,734,016
Median 400,000
Standard Deviation 371,496,177
Sample Variance138009.4T
Range915M
R-Value 0.85
Mean Square Error40224.5T
R-Squared 0.73
Significance 0.000014
Slope 62,715,949
Total Sum of Squares2208150.6T

Ascendis Pharma Short and Long Term Debt Total History

The series below tracks Ascendis Pharma's Short and Long Term Debt Total over 10 periods, from 212,000 in 2012 to 914.99 million in 2026.
2026914.99 million
2025871.41 million
2024856.62 million
2023743.06 million
2022617.57 million
2021209.92 million
202091.97 million
201936.62 million
2013null
2012212,000

Correlation of Short and Long Term Debt Total With Other Accounts

The matrix below shows pairwise correlations between Ascendis Pharma's Short and Long Term Debt Total and related financial accounts. These coefficients measure linear association and do not imply causation.
Click cells to compare fundamentals

Related Fundamentals

Last ReportedEnd Of Year Estimate
Cash And Short Term Investments€ 615.78 million€ 380.03 million
Short Term Debt€ 486.32 million€ 510.64 million
Short and Long Term Debt€ 486.53 million€ 510.86 million
Short Term Coverage Ratios0.11x0.11x

Methodology, Assumptions & Data Sources

Period-over-period Short and Long Term Debt Total data for Ascendis Pharma is shown below. Period-over-period changes in this line item trace to underlying business decisions visible in the financial statements. As a technology-driven company, Ascendis Pharma's Short and Long Term Debt Total reflects financing obligations and working capital commitments tied to its operating model.

Reported values for Ascendis Pharma AS are derived from periodic company reporting and market reference feeds and standardized for analysis. Sell-side coverage, where present, supplements the data shown. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.

Editorial review and methodology oversight provided by: Raphi Shpitalnik, Junior Member of Macroaxis Editorial Board
Tools
Analysis
Directory
Company
2026 Macroaxis LLC Made with in San Francisco
Privacy Terms Widgets Feedback
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and conditions page.